INSIGHTS ON CLINICAL TRIAL DESIGN
-
Trends, Challenges, And Opportunities In Lung Cancer Clinical Development
Discover how precision medicine and novel therapeutics reshape lung cancer clinical development. Gain insights to overcome modern trial execution and global enrollment challenges.
-
4 Core Biomarker-Driven Study Designs In Oncology
Modern oncology demands smarter trial designs. Explore how enrichment, stratification, and basket models transform biomarker data into successful, regulatory-ready clinical programs.
-
Improving Rare Disease Recruitment With Data And AI
Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.
-
Community Connections: Leveraging Localized Patient Access In Clinical Trials
This roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.
-
Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies8/29/2025
Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
-
Why Amendments Break Trials and How Elosity R3 Fixes It7/31/2026
Protocol amendments are inevitable. The challenge is managing them without disrupting trial execution.
-
Navigating Pediatric Clinical Trials: Challenges And Specific Strategies For Success5/2/2025
Advance your understanding of pediatric therapeutics with experts who will help you to navigate the complexities of designing age-specific trials and overcome specimen collection obstacles.
-
Navigating The Complex World Of First In Human Oncology Trials5/6/2025
First-in-human oncology trials are critical touchpoints in the development of novel cancer therapies, requiring precise scientific execution and a deeply patient-centric approach.
-
Why Are Sponsors Prioritizing Ophthalmology Clinical Trials?3/18/2026
Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Learn how specialized clinical expertise and global site networks accelerate complex trials. Streamline recruitment and advance novel therapies with proven operational solutions.
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Explore an innovative, automated approach that streamlines processes, strengthens financial controls, and accelerates readiness for Equity Events/Sox Controls, and much more.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.